Raúl Cabello

Raúl Cabello

Auto-generated profile, based on publicly available information

Raúl Cabello


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in Revista de Investigaciones Veterinarias del Perú
Verified
Journal Article
Open access
José Luis Marcos CamusJosé Luis Marcos Camus
José Luis Marcos Camus
RCRaúl Cabello
Raúl Cabello
YOYerko Olivares
Yerko Olivares
GQGonzalo Salvador Bustos Quevedo
Gonzalo Salvador Bustos Quevedo
JFJeniffer Ferrada
Jeniffer Ferrada
Ricardo Campos-SotoRicardo Campos-Soto
Ricardo Campos-Soto
Racehorses are subjected to intensive training, often leading to musculoskeletal injuries that require management with non-steroidal anti-inflammatory drugs (NSAIDs). In Chile, the Consejo Nacional de la Hípica regulates equine sports and classifies NSAIDs, including phenylbutazone (PBZ), as doping agents. However, current pharmacokinetic data are limited, relying on small sample sizes that may affect their applicability. This study evaluated the elimination pharmacokinetics of IV-administered PBZ (4.4 mg/kg) in two groups of Thoroughbred racehorses: pre-competition horses (5 years). In the younger group, the elimination half-life was 3.69 h, C₀ was 17.58 mg/L, volume of distribution was 180 L, and clearance was 34.35 L/h, while in the older group, these values were 3.5 h, 19.62 mg/L, 108 L, and 27.95 L/h, respectively, with no significant differences between groups. These findings suggest that PBZ elimination kinetics are comparable across different age groups and provide relevant evidence for the formulation of regulatory policies in the field of equine sports medicine.